New insights into atypical Alzheimer's disease in the era of biomarkers.
Graff-Radford J, Yong KXX, Apostolova LG, Bouwman FH, Carrillo M, Dickerson BC, Rabinovici GD, Schott JM, Jones DT, Murray ME.
Lancet Neurol. 2021 Mar;20(3):222-234. doi: 10.1016/S1474-4422(20)30440-3.
Late-onset Alzheimer Disease.
Rabinovici GD.
Continuum (Minneap Minn). 2019 Feb;25(1):14-33. doi: 10.1212/CON.0000000000000700.
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA.
Science. 1993 Aug 13;261(5123):921-3. doi: 10.1126/science.8346443.
Animal models of Alzheimer's disease: Applications, evaluation, and perspectives.
Chen ZY, Zhang Y.
Zool Res. 2022 Nov 18;43(6):1026-1040. doi: 10.24272/j.issn.2095-8137.2022.289.
Early-Onset Alzheimer Disease.
Mendez MF.
Neurol Clin. 2017 May;35(2):263-281. doi: 10.1016/j.ncl.2017.01.005.
Early-onset Alzheimer Disease and Its Variants.
Mendez MF.
Continuum (Minneap Minn). 2019 Feb;25(1):34-51. doi: 10.1212/CON.0000000000000687.
Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies.
Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G.
Nat Rev Neurol. 2019 Sep;15(9):501-518. doi: 10.1038/s41582-019-0228-7. Epub 2019 Jul 31.
Late-Onset Alzheimer Disease.
Pierce AL, Bullain SS, Kawas CH.
Neurol Clin. 2017 May;35(2):283-293. doi: 10.1016/j.ncl.2017.01.006.
Early- and late-onset Alzheimer disease: Are they the same entity?
Tellechea P, Pujol N, Esteve-Belloch P, Echeveste B, García-Eulate MR, Arbizu J, Riverol M.
Neurologia (Engl Ed). 2018 May;33(4):244-253. doi: 10.1016/j.nrl.2015.08.002. Epub 2015 Nov 3.
Is Late-Onset Alzheimer Disease Spelled "ATV(N)"?
Hughes TM, Hajjar I.
Neurology. 2021 Jul 27;97(4):155-156. doi: 10.1212/WNL.0000000000012259. Epub 2021 May 24.
